929039-04-3

Basic information

• Product Name: [4-(4-chloro-benzyl)-7-fluoro-5-methanesulfonyl-1-oxo-1,2,3,4-tetrahydro-cyclopenta[b]indol-3-yl]-acetic acid methyl ester
• CAS NO: 929039-04-3
• Molecular Weight: 463.914
• Mol File: 929039-04-3.mol

Chemical Properties

• CAS DataBase Reference: [4-(4-chloro-benzyl)-7-fluoro-5-methanesulfonyl-1-oxo-1,2,3,4-tetrahydro-cyclopenta[b]indol-3-yl]-acetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(4-chloro-benzyl)-7-fluoro-5-methanesulfonyl-1-oxo-1,2,3,4-tetrahydro-cyclopenta[b]indol-3-yl]-acetic acid methyl ester(929039-04-3)
• EPA Substance Registry System: [4-(4-chloro-benzyl)-7-fluoro-5-methanesulfonyl-1-oxo-1,2,3,4-tetrahydro-cyclopenta[b]indol-3-yl]-acetic acid methyl ester(929039-04-3)

Safety Data

• Hazardous Substances Data: 929039-04-3(Hazardous Substances Data)

Upstream product

• 571170-90-6 [5-bromo-4-(4-chloro-benzyl)-7-fluoro-1-oxo-1,2,3,4-tetrahydro-cyclopenta[b]indol-3-yl]-acetic acid methyl ester 
• 20277-69-4 sodium methansulfinate 
• 571170-89-3 [5-bromo-4-(4-chloro-benzyl)-7-fluoro-1,2,3,4-tetrahydro-cyclopenta[b]indol-3-yl]-acetic acid methyl ester 

Relevant articles and documents

In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites

Metabolites of the potent DP antagonist, MK-0524, were generated using in vitro systems including hepatic microsomes and hepatocytes. Four metabolites (two hydroxylated diastereomers, a ketone and an acyl glucuronide) were characterized by LC-MS/MS and s